We only have this paper's title and publication details.
Read it at the sourceResearch shows mTOR inhibitors enhance PEGPH20 effectiveness in pancreatic neuroendocrine tumors, suggesting improved cancer treatment options.
mTOR inhibitors enhanced the effectiveness of PEGPH20
No takes yet. Share an insight, caveat, or question.
Lou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: